Vaccination

Study shows lower antibody cross-reactivity after infection with the B.1.1.7 SARS-CoV-2 difference

Results of a phase 2 trial of the Novavax reconstituted SARS-CoV-2 nanoparticle vaccine

Pfizer SARS-CoV-2 vaccine effective from day 11 after 1d vaccine

Probabilistic predictions of the impact of vaccines and changes in the US COVID pathway

Most recent: Inflammation at a Dutch virus test center; no one was injured

AstraZeneca vaccine works in older adults, UK says

A single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospital risk by up to 80%, study shows

Covid vaccine side effects, enlarged lymph nodes, can be mistaken for cancer

A new vaccination strategy could eliminate the bacteria that cause UTIs

Spinal cord-free energy study of SARS-CoV-2 anxiety modifications